ASO Author Reflections: Total Thyroidectomy Versus Lobectomy for Differentiated Thyroid Cancer Carla ColomboSimone De LeoLaura Fugazzola ASO Author Reflections 08 January 2021 Pages: 4345 - 4346
Software-Based Analysis of the Taller-Than-Wide Feature of High-Risk Thyroid Nodules Ming-Hsun WuKuen-Yuan ChenChiung-Nien Chen Endocrine Tumors 03 January 2021 Pages: 4347 - 4357
ASO Author Reflections: Quantitative Shape Analysis of Thyroid Nodules: A Small But Important Step Towards Software-Based Preoperative Evaluation of Thyroid Nodules Ming-Hsun WuArgon Chen ASO Author Reflections 11 March 2021 Pages: 4358 - 4359
Construction and Validation of a Nomogram Based on the Log Odds of Positive Lymph Nodes to Predict the Prognosis of Medullary Thyroid Carcinoma After Surgery Jiajia TangShitao JiangYuxin Jiang Endocrine Tumors 19 January 2021 Pages: 4360 - 4370
ASO Author Reflections: The Prognostic Significance of LODDS in Medullary Thyroid Carcinoma Jiajia TangShitao JiangYuxin Jiang ASO Author Reflections 31 January 2021 Pages: 4371 - 4372
Impact of Dyslipidemia on the Risk of Second Cancer in Thyroid Cancer Patients: A Korean National Cohort Study Joon HoEunhwa KimYoung Suk Jo Endocrine Tumors 22 January 2021 Pages: 4373 - 4384
ASO Author Reflection: The Effect of Dyslipidemia on the Occurrence of Secondary Cancer in Patients With thyroid Cancer Joon HoEunhwa KimYoung Suk Jo ASO Author Reflections 22 March 2021 Pages: 4385 - 4386
Complications After Major Surgery for Duodenopancreatic Neuroendocrine Tumors in Patients with MEN1: Results from a Nationwide Cohort Dirk-Jan van BeekSjoerd NellMenno R. Vriens Endocrine Tumors Open access 31 January 2021 Pages: 4387 - 4399
ASO Author Reflections: Severe Morbidity After Major Surgery in Patients with MEN1 Dirk-Jan van BeekWessel M. C. M. VorselaarsMenno R. Vriens ASO Author Reflections Open access 27 January 2021 Pages: 4400 - 4401
Thoracic Duct Resection Has a Favorable Impact on Prognosis by Preventing Hematogenous Spread of Esophageal Cancer Cells: A Multi-institutional Analysis of 2269 Patients Koji TanakaMakoto YamasakiYuichiro Doki Gastrointestinal Oncology 16 April 2021 Pages: 4402 - 4410
ASO Author Reflection: Impact of Thoracic Duct Resection on Prognosis After Esophageal Cancer Surgery Koji TanakaMakoto YamasakiYuichiro Doki ASO Author Reflections 15 April 2021 Pages: 4411 - 4412
Effect of Additional Trastuzumab in Neoadjuvant and Adjuvant Treatment for Patients with Resectable HER2-Positive Gastric Cancer Qifei HeJiahui ChenJiafu Ji Gastrointestinal Oncology 03 January 2021 Pages: 4413 - 4422
Treatment at an Academic Cancer Center Confers Better Survival by Stage for Signet-Ring Cell and Non-signet-Ring Cell Gastric Cancer Maitham A. MoslimMichael J. MinarichJeffrey M. Farma Gastrointestinal Oncology 03 January 2021 Pages: 4423 - 4432
Cytoreductive Surgery for Selected Patients Whose Metastatic Gastric Cancer was Treated with Systemic Chemotherapy Yaniv BergerMihai GiurcanuKiran K. Turaga Gastrointestinal Oncology 08 January 2021 Pages: 4433 - 4443
Impact of the Interval Between Neoadjuvant Chemotherapy and Gastrectomy on Short- and Long-Term Outcomes for Patients with Advanced Gastric Cancer Augustinas BausysToomas ÜmarikKestutis Strupas Gastrointestinal Oncology 08 January 2021 Pages: 4444 - 4455
ASO Author Reflections: Gastrectomy Within 30 Days After Neoadjuvant Chemotherapy is Associated with the Highest Rate of Major Pathologic Response in Advanced Gastric Cancer Arvo ReinsooAugustinas BausysKestutis Strupas ASO Author Reflections 08 January 2021 Pages: 4456 - 4457
Appropriate Number of Adjuvant Chemotherapy Cycles for Patients with Stage 2 or 3 Gastric Cancer After Curative Gastrectomy: A Multicenter Cohort Study Sang-Ho JeongMoon-Won YooJae-Seok Min Gastrointestinal Oncology 10 January 2021 Pages: 4458 - 4470
Prediction Model for Screening Patients at Risk of Malnutrition After Gastric Cancer Surgery Ji-Hyeon ParkEunjung KimHyuk-Joon Lee Gastrointestinal Oncology 22 January 2021 Pages: 4471 - 4481
ASO Author Reflections: How Can We Accurately Predict Patients Expected to Be Malnourished After Gastrectomy? Ji-Hyeon ParkEunjung KimHyuk-Joon Lee ASO Author Reflections 23 January 2021 Pages: 4482 - 4483
Failure to Cure in Patients Undergoing Surgery for Gastric Cancer: A Nationwide Cohort Study Daan M. VoetenLeonie R. van der Werfon behalf of the Dutch Upper Gastrointestinal Cancer Audit Group Gastrointestinal Oncology Open access 23 January 2021 Pages: 4484 - 4496
ASO Author Reflections: Failure to Cure in Patients Undergoing Surgery for Gastric Cancer: A Nationwide Cohort Study Daan M. VoetenMark I. van Berge Henegouwen ASO Author Reflections Open access 27 January 2021 Pages: 4497 - 4498
Impact of Perioperative Blood Transfusions on Outcomes After Hyperthermic Intraperitoneal Chemotherapy: A Propensity-Matched Analysis Boateng KubiRichard NudotorJonathan B. Greer Gastrointestinal Oncology 28 January 2021 Pages: 4499 - 4507
ASO Author Reflections: Evidence for Limiting Perioperative Allogenic Blood Transfusions for Patients Undergoing CRS/HIPEC Boateng KubiFabian M. JohnstonJonathan B. Greer ASO Author Reflections 09 January 2021 Pages: 4508 - 4509
Validation of the 8th Edition Nodal Staging and Proposal of New Nodal Categories for Future Editions of the TNM Classification of Non-Small Cell Lung Cancer Shaolei LiShi YanNan Wu Thoracic Oncology 02 January 2021 Pages: 4510 - 4516
ASO Author Reflections: Proposed Nodal Categories for Future Editions of the TNM Classification of Non-small Cell Lung Cancer Shaolei LiNan Wu ASO Author Reflections 09 January 2021 Pages: 4517 - 4518
Impact of Lymph Node Ratio on Survival Outcome in Esophageal Squamous Cell Carcinoma After Minimally Invasive Esophagectomy Yu KitamuraTaro OshikiriYoshihiro Kakeji Thoracic Oncology 03 January 2021 Pages: 4519 - 4528
ASO Author Reflections: The Lymph Node Ratio is an Independent Prognostic Factor in Esophageal Squamous Cell Carcinoma After Minimally Invasive Esophagectomy Yu KitamuraTaro Oshikiri ASO Author Reflections 05 January 2021 Pages: 4529 - 4529
The Impact of Pretherapeutic Naples Prognostic Score on Survival in Patients with Locally Advanced Esophageal Cancer Kazuki KanoTakanobu YamadaTakashi Oshima Thoracic Oncology 09 January 2021 Pages: 4530 - 4539
ASO Author Reflections: Pretherapeutic Naples Prognostic Score in Locally Advanced Esophageal Cancer Kazuki KanoTakanobu YamadaTakashi Oshima ASO Author Reflections 28 January 2021 Pages: 4540 - 4541
Pulmonary Metastasectomy in Patients with Lung Metastases from Nasopharyngeal Carcinoma Ze-Rui ZhaoDi-Han LiuHao Long Thoracic Oncology 25 January 2021 Pages: 4542 - 4550
ASO Author Reflections: Pulmonary Metastasectomy in Patients with Lung Metastases from Nasopharyngeal Carcinoma Ze-Rui ZhaoHao Long ASO Author Reflections 14 February 2021 Pages: 4551 - 4552
Multidisciplinary Surgical Approach to Increase Complete Cytoreduction Rates for Advanced Ovarian Cancer in a Tertiary Gynecologic Oncology Center Karen M. MulliganKate GlennonDonal J. Brennan Gynecologic Oncology 10 January 2021 Pages: 4553 - 4560
Performance of Long-Term CT and PET/CT Surveillance for Detection of Distant Recurrence in Patients with Resected Stage IIIA–D Melanoma Robin M. TurnerMbathio DiengRachael L. Morton Melanoma 03 January 2021 Pages: 4561 - 4569
ASO Author Reflections: Longitudinal Diagnostic Accuracy of Surveillance Imaging in Resected Stage III Melanoma Patients Mbathio DiengRachael L. Morton ASO Author Reflections 02 January 2021 Pages: 4570 - 4571
Novel Prognostic Models Predicting the Cancer-Specific Survival in Patients with Cutaneous Melanoma Based on Metastatic Lymph Node Status Wei LiXuewen XuYange Zhang Melanoma 11 January 2021 Pages: 4572 - 4581
Evaluation of a Gene Expression Profiling Assay in Primary Cutaneous Melanoma Aaron W. Kangas-DickAlissa GreenbaumVadim Koshenkov Melanoma 23 January 2021 Pages: 4582 - 4589
ASO Author Reflections: Gene Expression Profiling for Melanoma: Is it Ready for Prime Time? Aaron Kangas-DickAdam C. BergerVadim Koshenkov ASO Author Reflections 21 January 2021 Pages: 4590 - 4591
Intraoperative Radiation Mitigates the Effect of Microscopically Positive Tumor Margins on Survival Among Pancreatic Adenocarcinoma Patients Treated with Neoadjuvant FOLFIRINOX and Chemoradiation Yurie SekigamiTheodoros MichelakosCristina R. Ferrone Pancreatic Tumors 03 January 2021 Pages: 4592 - 4601
R Status is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma Stefano CrippaFabio GiannoneMassimo Falconi Pancreatic Tumors 03 January 2021 Pages: 4602 - 4612
ASO Author Reflections: R Status Is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma Stefano CrippaFabio GiannoneMassimo Falconi ASO Author Reflections 14 February 2021 Pages: 4613 - 4614
Measurement of Portal Vein Blood Circulating Tumor Cells is Safe and May Correlate With Outcomes in Resected Pancreatic Ductal Adenocarcinoma Michael G. WhiteAndrew LeeChing-Wei D. Tzeng Pancreatic Tumors 07 January 2021 Pages: 4615 - 4622
ASO Author Reflections: Potential Role of Circulating Biomarkers in Resected Pancreatic Adenocarcinoma Michael G. WhiteChing-Wei D. Tzeng ASO Author Reflections 28 January 2021 Pages: 4623 - 4624
Pancreatectomy with Vascular Resection After Neoadjuvant FOLFIRINOX: Who Survives More Than a Year After Surgery? Jonathan GarnierFabien RobinOlivier Turrini Pancreatic Tumors 18 January 2021 Pages: 4625 - 4634
ASO Author Reflections: Which Patient will Benefit from Complex Vascular Resection during Pancreatectomy? Jonathan GarnierLaurent SulpiceOlivier Turrini ASO Author Reflections 16 January 2021 Pages: 4635 - 4636
Phase II Trial of Adjuvant Dendritic Cell Vaccine in Combination with Celecoxib, Interferon-α, and Rintatolimod in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases Rajesh RamanathanHaroon ChoudryDavid L. Bartlett Peritoneal Surface Malignancy 05 January 2021 Pages: 4637 - 4646
Perioperative Management of Gastric Cancer Patients Treated With (Sub)Total Gastrectomy, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Lessons Learned W. J. KoemansA. HouwinkJ. W. van Sandick Peritoneal Surface Malignancy 02 January 2021 Pages: 4647 - 4654
Outcomes for Elderly Ovarian Cancer Patients Treated with Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) Katherin Zambrano-VeraArmando SardiTeresa Diaz-Montes Peritoneal Surface Malignancy 03 January 2021 Pages: 4655 - 4666
ASO Author Reflections: The Frailty of Patient Selection Katherin Zambrano-VeraArmando SardiTeresa Diaz-Montes ASO Author Reflections 04 January 2021 Pages: 4667 - 4667
Impact of Surgical Modalities on Long-term Survival Outcomes of Patients with Duodenal Gastrointestinal Stromal Tumor You-Zhu WeiZhi-Bin CaiXiao-Feng Zhang Peritoneal Surface Malignancy 03 January 2021 Pages: 4668 - 4674
ASO Author Reflections: Impact of Surgical Methods on Long-Term Survival Outcomes for Patients with Duodenal Gastrointestinal Stromal Tumor You-Zhu WeiYan-Ming Zhou ASO Author Reflections 17 January 2021 Pages: 4675 - 4675